Back to Agenda
Evidence-Based Insights Informing Participant Compensation Strategies
Session Chair(s)
Kenneth Getz, MBA
Tufts Center for the Study of Drug Development
Tufts University School of Medicine, United States
This session presents findings from a DIA–Tufts CSDD study examining how participant compensation strategies vary across trial phases and therapeutic areas and their impact on recruitment, retention, and enrollment outcomes, with implications for protocol design and trial execution
Learning Objective : Describe how participant compensation strategies vary by trial phase and therapeutic area; Assess evidence linking compensation practices to recruitment, retention, and enrollment outcomes; Apply study insights to support consistent, ethical, and effective compensation decisions in protocol design and trial execution.
Have an account?